The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia

Overview of attention for article published in Frontiers in Physiology, January 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 10,977 followers.

Selumetinib Attenuates Tumor Growth but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia. https://t.co/rvMdEnQWKa

The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against… https://t.co/hF8ORGWUkF

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.